Developing New Agents to Treat Hypoactive Sexual Desire Disorder

There is currently only one pharmacologic treatment approved for the treatment of hypoactive sexual desire disorder. There is work being done to find new ways to help these patients have a normal sex life.

Sheryl Kingsberg, PhD, discussed the need for additional treatment options during the annual meeting of the North American Menopause Society in Orlando. Noting a controversey in the ways the condition is treated, Kingsberg said it is a combination of psychological, sociocultural, and neroanatomy issues that can all contribute to the development of this condition. The lone treatment has so far only been approved in pre-menopausal women, but Kingsberg said it can be used in pre- and post-menopausal women.